EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Editorial: Chimeric antigen receptor T cell therapies and bispecific antibodies in hematologic malignancies

Yangmin Zhu

Frontiers in Oncology · 18.08.2026 · 16

DOI: 10.3389/fonc.2026.1936446 ↗

Kurz gefasst

Editorial in der Zeitschrift Frontiers in Oncology, online erschienen am 18.08.2026. Verfasst von Yangmin Zhu. Beteiligte Einrichtung: The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

bispecific antibodieschimeric antigen receptorhematologic malignanciesleukemialymphomamyeloma

Autor:innen und Institutionen

  • The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China.

Zitieren

APA

Zhu, Y. (2026). Editorial: Chimeric antigen receptor T cell therapies and bispecific antibodies in hematologic malignancies. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1936446

Vancouver

Zhu Y. Editorial: Chimeric antigen receptor T cell therapies and bispecific antibodies in hematologic malignancies. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1936446

BibTeX
@article{Zhu2026,
  author = {Zhu, Yangmin},
  title = {Editorial: Chimeric antigen receptor T cell therapies and bispecific antibodies in hematologic malignancies},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1936446}
}
Kostenlos starten →